BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36180688)

  • 1. Alternative Ligands at Melatonin Receptors.
    Legros C; Yous S; Boutin JA
    Methods Mol Biol; 2022; 2550():151-162. PubMed ID: 36180688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the chicken brain melatonin-binding protein using iodinated and tritiated ligands.
    Kennaway DJ; Hugel HM; Rowe SA
    J Pineal Res; 1994 Oct; 17(3):137-48. PubMed ID: 7897586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring Binding at the Putative Melatonin Receptor MT3.
    Legros C; Dupuis P; Ferry G; Boutin JA
    Methods Mol Biol; 2022; 2550():283-289. PubMed ID: 36180699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative Radioligands for Investigating the Molecular Pharmacology of Melatonin Receptors.
    Legros C; Brasseur C; Delagrange P; Ducrot P; Nosjean O; Boutin JA
    J Pharmacol Exp Ther; 2016 Mar; 356(3):681-92. PubMed ID: 26759496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular determinants for the differential coupling of Galpha(16) to the melatonin MT1, MT2 and Xenopus Mel1c receptors.
    Lai FP; Mody SM; Yung LY; Kam JY; Pang CS; Pang SF; Wong YH
    J Neurochem; 2002 Mar; 80(5):736-45. PubMed ID: 11948236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-bromoacetyl 5-methoxytryptamine: an irreversible melatonin ligand?
    Chong NW; Evans JE; Sugden D
    Biochem Biophys Res Commun; 1993 Jun; 193(3):1355-61. PubMed ID: 8391805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3/QR2. Tissue distribution of MT3/QR2 .
    Nosjean O; Nicolas JP; Klupsch F; Delagrange P; Canet E; Boutin JA
    Biochem Pharmacol; 2001 Jun; 61(11):1369-79. PubMed ID: 11331072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-[
    Gbahou F; Jockers R
    Methods Mol Biol; 2022; 2550():141-149. PubMed ID: 36180687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-[125I]iodomelatonin binding sites in hamster brain membranes: pharmacological characteristics and regional distribution.
    Duncan MJ; Takahashi JS; Dubocovich ML
    Endocrinology; 1988 May; 122(5):1825-33. PubMed ID: 2834175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new melatonin receptor ligand with mt1-agonist and MT2-antagonist properties.
    Nonno R; Lucini V; Spadoni G; Pannacci M; Croce A; Esposti D; Balsamini C; Tarzia G; Fraschini F; Stankov BM
    J Pineal Res; 2000 Nov; 29(4):234-40. PubMed ID: 11068946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning, Expression, Purification, Crystallization, and X-Ray Structural Determination of the Human NQO2 in Complex with Melatonin.
    Calamini B; Ferry G; Boutin JA
    Methods Mol Biol; 2022; 2550():291-304. PubMed ID: 36180700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Methoxytryptamine inhibits cyclic AMP accumulation in cultured retinal neurons through activation of a pertussis toxin-sensitive site distinct from the 2-[125I]iodomelatonin binding site.
    Iuvone PM; Gan J; Alonso-Gómez AL
    J Neurochem; 1995 Apr; 64(4):1892-5. PubMed ID: 7891120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-(125I) iodomelatonin binding sites in rat adrenals: pharmacological characteristics and subcellular distribution.
    Persengiev SP
    Life Sci; 1992; 51(9):647-51. PubMed ID: 1323736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of 2-[125I]iodomelatonin to characterize melatonin binding sites in chicken retina.
    Dubocovich ML; Takahashi JS
    Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3916-20. PubMed ID: 3035559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin receptor-mediated inhibition of cyclic AMP accumulation in chick retinal cell cultures.
    Iuvone PM; Gan J
    J Neurochem; 1994 Jul; 63(1):118-24. PubMed ID: 7515941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2[125I]Iodomelatonin binding sites in guinea pig platelets.
    Yau MY; Pang CS; Kravtsov G; Pang SF; Shiu SY
    J Pineal Res; 2002 Mar; 32(2):97-105. PubMed ID: 12071474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New radioligands for describing the molecular pharmacology of MT1 and MT2 melatonin receptors.
    Legros C; Matthey U; Grelak T; Pedragona-Moreau S; Hassler W; Yous S; Thomas E; Suzenet F; Folleas B; Lefoulon F; Berthelot P; Caignard DH; Guillaumet G; Delagrange P; Brayer JL; Nosjean O; Boutin JA
    Int J Mol Sci; 2013 Apr; 14(5):8948-62. PubMed ID: 23698757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology and function of melatonin receptors.
    Dubocovich ML
    FASEB J; 1988 Sep; 2(12):2765-73. PubMed ID: 2842214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-[125I]iodomelatonin labels sites with identical pharmacological characteristics in chicken brain and chicken retina.
    Dubocovich ML; Shankar G; Mickel M
    Eur J Pharmacol; 1989 Mar; 162(2):289-99. PubMed ID: 2542059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity labeling of melatonin binding sites in the hamster brain.
    Anis Y; Zisapel N
    Biochem Biophys Res Commun; 1991 Aug; 178(3):1147-52. PubMed ID: 1651713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.